A New Thiopeptide Antibiotic, Micrococcin P3, from a Marine-Derived Strain of the Bacterium
Overview
Authors
Affiliations
A new thiopeptide (micrococcin P3, ) and a known one (micrococcin P1, ) were isolated from the culture broth of a marine-derived strain of . The structures of both compounds were elucidated using spectroscopic methods, including extensive 1D and 2D NMR analysis, high resolution mass spectrometry (HRMS), and tandem mass spectrometry. Both compounds exhibited potent antibacterial activities against Gram-positive strains with minimum inhibitory concentration (MIC) values of 0.05-0.8 μg/mL and did not show cytotoxicity in the MTT assay up to a concentration of 10 μM. This study adds a new promising member, micrococcin P3, to the family of thiopeptide antibiotics, which shows potential for the development of new antibiotics targeting Gram-positive bacteria.
Study of marine microorganism metabolites: new resources for bioactive natural products.
Barzkar N, Sukhikh S, Babich O Front Microbiol. 2024; 14:1285902.
PMID: 38260902 PMC: 10800913. DOI: 10.3389/fmicb.2023.1285902.
Xiao S, Chen N, Chai Z, Zhou M, Xiao C, Zhao S Mar Drugs. 2022; 20(9).
PMID: 36135756 PMC: 9501603. DOI: 10.3390/md20090567.
Micrococcin P1 and P2 from Epibiotic Bacteria Associated with Isolates of from Kenya.
Dzeha T, Hall M, Burgess J Mar Drugs. 2022; 20(2).
PMID: 35200657 PMC: 8878052. DOI: 10.3390/md20020128.
Srinivasan R, Kannappan A, Shi C, Lin X Mar Drugs. 2021; 19(10).
PMID: 34677431 PMC: 8539464. DOI: 10.3390/md19100530.